EXOSC7

exosome component 7, the group of Exosome complex

Basic information

Region (hg38): 3:44975241-45036066

Links

ENSG00000075914NCBI:23016OMIM:606488HGNC:28112Uniprot:Q15024AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the EXOSC7 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXOSC7 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
19
clinvar
19
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 19 0 0

Variants in EXOSC7

This is a list of pathogenic ClinVar variants found in the EXOSC7 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-44976281-G-T not specified Uncertain significance (May 30, 2023)2552801
3-44976299-G-C not specified Uncertain significance (Sep 19, 2023)3091217
3-44989149-C-T not specified Uncertain significance (Jan 29, 2024)3091218
3-44989150-G-A not specified Uncertain significance (Apr 17, 2023)2569202
3-44989180-G-A not specified Uncertain significance (Feb 14, 2024)3091222
3-44989188-G-A not specified Uncertain significance (May 17, 2023)2524891
3-44989227-G-A not specified Uncertain significance (Feb 10, 2022)2389346
3-44989593-C-T not specified Uncertain significance (Jun 09, 2022)2385590
3-44997098-C-T not specified Uncertain significance (Mar 26, 2024)3276845
3-44997163-C-T not specified Uncertain significance (Mar 29, 2024)3276846
3-44997184-A-G not specified Uncertain significance (Jul 06, 2021)2412458
3-44997196-A-C not specified Uncertain significance (Jun 16, 2023)2593580
3-45001542-T-C not specified Uncertain significance (Aug 22, 2023)2620644
3-45005319-G-A not specified Uncertain significance (Nov 09, 2021)2365692
3-45005354-C-G not specified Uncertain significance (Feb 16, 2023)2485480
3-45005371-G-A not specified Uncertain significance (Dec 13, 2022)2393757
3-45007433-A-G not specified Uncertain significance (Aug 26, 2022)2350702
3-45007541-G-C not specified Uncertain significance (Mar 12, 2024)3091219
3-45007567-A-G not specified Uncertain significance (Aug 13, 2021)2245066
3-45007567-A-T not specified Uncertain significance (Dec 18, 2023)3091221
3-45011299-G-A not specified Uncertain significance (Aug 04, 2023)2616221
3-45026394-G-A not specified Uncertain significance (Jun 22, 2021)2373877
3-45026426-G-A not specified Uncertain significance (Sep 29, 2022)2210020
3-45035536-G-A not specified Uncertain significance (Jun 24, 2022)2381901
3-45035684-G-C not specified Uncertain significance (Sep 27, 2021)2252088

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
EXOSC7protein_codingprotein_codingENST00000265564 860826
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00001040.8121256830651257480.000258
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2371751661.050.000009131880
Missense in Polyphen4141.5780.98609455
Synonymous1.435165.80.7750.00000380569
Loss of Function1.301015.50.6449.05e-7179

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005560.000551
Ashkenazi Jewish0.0001980.000198
East Asian0.0001090.000109
Finnish0.00004650.0000462
European (Non-Finnish)0.0003520.000352
Middle Eastern0.0001090.000109
South Asian0.0003270.000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes.;
Pathway
RNA degradation - Homo sapiens (human);Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;mRNA decay by 3, to 5, exoribonuclease;Deadenylation-dependent mRNA decay (Consensus)

Recessive Scores

pRec
0.269

Intolerance Scores

loftool
0.827
rvis_EVS
-0.03
rvis_percentile_EVS
51.92

Haploinsufficiency Scores

pHI
0.635
hipred
Y
hipred_score
0.713
ghis
0.584

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.958

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Exosc7
Phenotype

Gene ontology

Biological process
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;RNA catabolic process;rRNA catabolic process;nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';U1 snRNA 3'-end processing;U4 snRNA 3'-end processing;U5 snRNA 3'-end processing;regulation of mRNA stability;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;nuclear mRNA surveillance;nuclear polyadenylation-dependent rRNA catabolic process;nuclear polyadenylation-dependent tRNA catabolic process;nuclear polyadenylation-dependent mRNA catabolic process
Cellular component
nuclear exosome (RNase complex);cytoplasmic exosome (RNase complex);exosome (RNase complex);nucleoplasm;nucleolus;cytosol
Molecular function
3'-5'-exoribonuclease activity;RNA binding;exoribonuclease activity;protein binding;AU-rich element binding